Prime Minister Narendra Modi launched various initiatives including TB-free panchayats, implementing a shorter TB Preventive Treatment (TPT...

Tuberculosis caused 1.6 million deaths globally in 2021, making it the world's leading cause of death from infectious disease, before COVID...

India has the world's highest TB burden-- 2.6 million active cases and close to 450,000 deaths each year from the infectious bacterial dise...

Noting the challenges posed by the COVID-19 pandemic, the minister said, "For more than two years, we have been facing the global pandemic ...

BPaL is a six-month, alloral, three-drug regimen that is used to treat people with highly drug-resistant forms of TB. It consists of the TB...

“If masks become routine in India, just like they are in Japan, then we could well meet our target of eliminating TB by 2025,” said pulmono...

The Drug Controller General of India (DCGI) has approved Pretomanid for conditional access under the National Tuberculosis Elimination Prog...

Pretomanid, a new oral treatment is a shorter more convenient option for people with extensively drug resistant (XDR) TB. The dossier for g...

In a landmark development, global biopharmaceutical company Sanofi will lower the price of Rifapentine, a critically important drug used to...

The new vaccine, known as M72/AS01E, was tested at 11 sites in Kenya, South Africa and Zambia in adults whose blood tests showed they had l...

The Global Fund was created in 2002. With public donors including the USA, UK, and private donors such as the Gates Foundation, it has used...

Multi-drug resistant TB is rapidly spreading with 450,000-odd new cases reported in 2012 by the World Health Organisation (WHO).

Vardhan said that an email repository will be built up for establishing connectivity between govt & all doctors in the country to help figh...

Approximately 8.6 million people worldwide develop active TB each year. Twenty-five per cent of all diagnosed TB patients are in India.

Countries like India and China, with high numbers of TB cases could gain more from the money they spend on diagnosis and treatment of the d...

Eli Lilly and Company has announced plans to invest an additional $50 million in a global partnership to fight Multi-Drug Resistant Tubercu...